• Home>
  • Stocks>
  • Jenburkt Pharmaceuticals Ltd Share Price
Jenburkt Pharmaceuticals Ltd share price logo

Jenburkt Pharmaceuticals Ltd Share Price

BSE: 524731

Small Cap

Healthcare Sector

₹1090.00

+10.00

(+0.93%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Jenburkt Pharmaceuticals Ltd Stock Performance

as on December 12, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,052
    ₹1,098.6
    downward going graph

    3.49%

    Downside

    0.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹936.7
    ₹1,410
    downward going graph

    14.06%

    Downside

    29.36%

    Upside

    downward going graph

Jenburkt Pharmaceuticals Ltd share price movements today

Previous Close
₹1,080.00
Open
₹1,086.60
Volume
412.00
Upper Circuit
₹1,296.00
Lower Circuit
₹864.00
Day's Low - High
₹1,052 - ₹1,098.6
52 Week Low - High
₹936.7 - ₹1,410

Jenburkt Pharmaceuticals Ltd Historical Returns

1 Month Return
-11.75 %
3 Month Return
-0.4 %
1 Year Return
-16.97 %
3 Year Return
+ 66.9 %
5 Year Return
+ 149.87 %

Jenburkt Pharmaceuticals Ltd Fundamentals

as on December 12, 2025 at 4:01 pm IST

Market Cap

₹480.85 Cr

Return on Equity (ROE)

20.25

PE Ratio (TTM)

0

Return on capital employed (ROCE)

27.18

Beta (LTM)

0.79

P/B Ratio

2.6

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

5.83

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Jenburkt Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jenburkt Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Jenburkt Pharmaceuticals Ltd image
Jenburkt Pharmaceuticals Ltd
NA480.8529.97%0.0032151
Phaarmasia Ltd image
Phaarmasia Ltd
NA63.2351.48%0.00-224
Sanofi Consumer Healthcare India Ltd image
Sanofi Consumer Healthcare India Ltd
BUY10,633.70-1.17%0.00181724
Gujarat Terce Laboratories Ltd image
Gujarat Terce Laboratories Ltd
NA33.09102%0.00-150
Innova Captab Ltd image
Innova Captab Ltd
BUY4,128.216.65%0.631281,243
See all

Jenburkt Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Jenburkt Pharmaceuticals Ltd Stock has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-90% versus previous 30 day period

Jenburkt Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
34.57
35.2
29.18
38.29
35.66
38.84
32.54
41.22
36.89
41.05
35.53
45.56
Other Income
1.46
1.26
1.04
1.1
1.35
1.19
1.41
1.85
1.58
1.88
2.06
2.08
Total Income
36.03
36.45
30.21
39.38
37.01
40.03
33.94
43.07
38.47
42.93
37.58
47.64
Expenses
27.59
27.7
22.21
29.18
28.47
28.99
23.25
29.79
28.07
30.19
26.57
32.45
Operating Profit
6.98
7.5
6.97
9.11
7.19
9.85
9.29
11.43
8.82
10.86
8.96
13.11
Operating Profit Margin %
20.19%
21.31%
23.89%
23.79%
20.16%
25.36%
28.55%
27.73%
23.91%
26.46%
25.22%
28.78%
Profit Before Interest, Tax and Depreciation
8.44
8.75
8
10.2
8.54
11.04
10.7
13.28
10.4
12.74
11.01
15.18
Interest
0.1
0.08
0.07
0.07
0.07
0.06
0.11
0.12
0.11
0.11
0.11
0.11
Depreciation
0.58
0.59
0.5
0.59
0.63
0.62
0.52
0.64
0.78
0.79
0.72
0.74
Profit Before Tax
7.76
8.08
7.43
9.54
7.84
10.36
10.07
12.52
9.51
11.84
10.18
14.33
Tax Paid
2.32
1.72
2.06
2.22
2.44
2.48
2.65
2.92
3.01
3.3
2.39
4.17
Profit After Tax
5.43
6.35
5.37
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
Total Net profit including share of profit / Loss from associate company
5.43
6.35
5.37
7.32
5.4
7.88
7.42
9.6
6.51
8.54
7.79
10.16
EPS
11.84
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
Actual EPS
11.84
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
Adjusted EPS
11.84
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03
Diluted EPS
11.84
13.92
12.17
16.59
12.25
17.86
16.8
21.75
14.75
19.34
17.66
23.03

Jenburkt Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
103.31
114.67
122.64
118.89
109.29
123.98
136.75
141.97
151.69
Other Income
2.96
3.39
3.41
4.22
4.31
4.95
5.12
4.67
6.72
Total Income
106.26
118.07
126.05
123.11
113.6
128.93
141.87
146.63
158.41
Expenses
83.59
90.89
97.68
99.15
89.45
96.73
106.38
108.85
111.3
Operating Profit
19.72
23.78
24.96
19.74
19.84
27.25
30.37
33.12
40.39
Operating Profit Margin %
19.09%
20.74%
20.35%
16.6%
18.15%
21.98%
22.21%
23.33%
26.63%
Profit Before Interest, Tax and Depreciation
22.68
27.18
28.37
23.96
24.15
32.2
35.49
37.79
47.11
Interest
0.41
0.41
0.39
0.53
0.47
0.43
0.37
0.27
0.45
Depreciation
1.79
1.5
1.35
2.3
2.04
1.9
2.26
2.34
2.73
Profit Before Tax
20.48
25.27
26.63
21.13
21.64
29.87
32.86
35.18
43.93
Tax Paid
6.97
8.05
6.83
6.27
5.14
7.58
8.25
9.2
11.87
Profit After Tax
13.51
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
Total Net profit including share of profit / Loss from associate company
13.51
17.21
19.8
14.87
16.5
22.3
24.61
25.98
32.06
EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Actual EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Adjusted EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65
Diluted EPS
29.05
37.5
43.14
32.4
35.96
48.58
53.9
58.86
72.65

Jenburkt Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
7.82
9.95
16.18
12.99
15.02
19.45
9.27
17.05
8.12
27.91
Cash Flow from Investing Activities
-0.27
-9.77
1.01
-10.53
-2.87
-18.78
-1.19
2.62
-0.59
-17.05
Cash Flow from Financing Activities
-5.42
0.68
-17.98
-2.43
-10.84
-0.72
-5.53
-21.05
-7.08
-7.62
Net Cash Flow
2.13
0.86
-0.8
0.04
1.31
-0.04
2.54
-1.37
0.47
3.24

Jenburkt Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Jenburkt Pharmaceuticals Ltd.

  • Jenburkt Pharmaceuticals Ltd Earnings Results

    Jenburkt Pharmaceuticals Ltd’s net profit jumped 5.83% since last year same period to ₹10.16Cr in the Q2 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 30.42% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Jenburkt Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹18.00 per share on 20 May 2025 - translating a dividend yield of 3.06%.

    Read More about Dividends

Insights on Jenburkt Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 132.8% return, outperforming this stock by 65.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.3% return, outperforming this stock by 30.3%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 53.22% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.67% to 46.66% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Jenburkt Pharma stock has moved down by -11.8%

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd. is a well-established healthcare and pharmaceutical venture, formed by the Bhuta family in 1985. By being listed on the Bombay Stock Exchange, Jenburkt is a public limited company that specializes in manufacturing and marketing high quality pharmaceutical formulations and healthcare products. Headquartered in Mumbai, Jenburkt runs all its operations from the same location.

Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.

Revenue: ₹45.56Cr as on September 2025 (Q2 FY26)
Net Profit: ₹10.16Cr as on September 2025 (Q2 FY26)
Chairperson Name: Ashish U Bhuta
OrganisationJenburkt Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish U Bhuta
E-voting on sharesClick here to vote

FAQs

What is Jenburkt Pharmaceuticals Ltd share price today?

Jenburkt Pharmaceuticals Ltd share price today stands at ₹1090 as on at the close of the market. Jenburkt Pharmaceuticals Ltd share today touched a day high of ₹1098.6 and a low of ₹1052.

What is the 52 week high and 52 week low range for Jenburkt Pharmaceuticals Ltd share?

Jenburkt Pharmaceuticals Ltd touched a 52 week high of ₹1410 and a 52 week low of ₹936.7. Jenburkt Pharmaceuticals Ltd share price today i.e. is closed at ₹1090, which is -22.70% down from its 52 week high and 16.37% up from its 52 week low.

What is Jenburkt Pharmaceuticals Ltd's market capitalisation today?

Jenburkt Pharmaceuticals Ltd market capitalisation is ₹480.85 Cr as on .

How to buy Jenburkt Pharmaceuticals Ltd shares?

To buy Jenburkt Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524731 or Jenburkt Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Jenburkt Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Jenburkt Pharmaceuticals Ltd trading volume today?

Jenburkt Pharmaceuticals Ltd trading volume is 412.00 as on . This means that 412.00 shares of Jenburkt Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.